Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 104.85
+3.31 (3.26%)
Apr 1, 2026, 3:00 PM CST
SHA:688016 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 554.66 | 502.1 | 492.43 | 356.88 | 315.86 |
Depreciation & Amortization | 79.06 | 46.35 | 35.27 | 33.17 | 23.71 |
Other Amortization | 10.65 | 14.31 | 10.95 | 10.83 | 2.86 |
Loss (Gain) From Sale of Assets | - | 0.66 | 0.1 | 0.23 | 0.06 |
Asset Writedown & Restructuring Costs | 8.99 | 4.69 | 6.35 | 2.23 | 2.62 |
Loss (Gain) From Sale of Investments | -15.98 | -87.41 | -9.15 | -4.1 | -15.01 |
Provision & Write-off of Bad Debts | - | 3.25 | 1.34 | 2.63 | 1.28 |
Other Operating Activities | 15.19 | -9.47 | -0.79 | -2.4 | -6.77 |
Change in Accounts Receivable | 90.93 | -157.78 | -31.75 | -48.38 | -41.56 |
Change in Inventory | -14.37 | -21.04 | -61.27 | -51.29 | -27.48 |
Change in Accounts Payable | -159.01 | 65.12 | 105.92 | 15.25 | 40.17 |
Change in Other Net Operating Assets | 14.29 | 18.22 | 18.05 | 15.45 | 10.88 |
Operating Cash Flow | 573.06 | 373.6 | 558.31 | 333.76 | 300.25 |
Operating Cash Flow Growth | 53.39% | -33.08% | 67.28% | 11.16% | 38.09% |
Capital Expenditures | -303.03 | -212.65 | -190.26 | -293.98 | -89.58 |
Sale of Property, Plant & Equipment | - | 0.04 | - | - | - |
Cash Acquisitions | - | -453.05 | - | -133.33 | - |
Investment in Securities | -100 | -97.5 | -10.11 | - | - |
Other Investing Activities | 15.98 | 30.02 | 23.28 | -12.5 | 15.01 |
Investing Cash Flow | -387.06 | -733.14 | -177.09 | -439.8 | -74.57 |
Short-Term Debt Issued | - | 14 | - | - | - |
Long-Term Debt Issued | 126 | - | - | 2.09 | - |
Total Debt Issued | 126 | 14 | - | 2.09 | - |
Short-Term Debt Repaid | - | - | -2.12 | - | - |
Long-Term Debt Repaid | -140 | -13.51 | -12.42 | -10.9 | -8.48 |
Total Debt Repaid | -140 | -13.51 | -14.54 | -10.9 | -8.48 |
Net Debt Issued (Repaid) | -14 | 0.49 | -14.54 | -8.81 | -8.48 |
Issuance of Common Stock | - | 35 | 1,781 | - | - |
Repurchase of Common Stock | - | -120 | - | - | - |
Common Dividends Paid | -201.83 | -450.46 | -165.55 | -151.15 | -64.78 |
Other Financing Activities | -134.08 | - | - | - | 33.41 |
Financing Cash Flow | -349.92 | -534.98 | 1,601 | -159.96 | -39.85 |
Foreign Exchange Rate Adjustments | -2.87 | 0.24 | - | - | - |
Net Cash Flow | -166.78 | -894.27 | 1,983 | -266 | 185.84 |
Free Cash Flow | 270.03 | 160.95 | 368.05 | 39.78 | 210.67 |
Free Cash Flow Growth | 67.77% | -56.27% | 825.13% | -81.12% | 10.17% |
Free Cash Flow Margin | 19.99% | 13.34% | 31.00% | 4.44% | 30.77% |
Free Cash Flow Per Share | 2.23 | 1.30 | 3.42 | 0.37 | 1.97 |
Cash Income Tax Paid | 178.45 | 284.06 | 174.23 | 140.79 | - |
Levered Free Cash Flow | 150.69 | 29.22 | 247.13 | -79.41 | 107.26 |
Unlevered Free Cash Flow | 150.69 | 30.25 | 248.27 | -78.1 | 108.36 |
Change in Working Capital | -79.51 | -100.88 | 21.8 | -65.7 | -24.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.